Boxer Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Boxer Capital’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-250,000	Closed	-$13.8M	–	89
2020 Q3	$13.8M	Hold	250,000	–	–	0.48%	46
2020 Q2	$15.8M	Hold	250,000	–	–	0.69%	38
2020 Q1	$12.8M	Hold	250,000	–	–	0.87%	32
2019 Q4	$19.9M	Hold	250,000	–	–	1.12%	26
2019 Q3	$12.1M	Hold	250,000	–	–	0.88%	27
2019 Q2	$13.2M	Hold	250,000	–	–	1.13%	22
2019 Q1	$13.2M	Sell	250,000 -450,000	-64%	-$22.1M	1.53%	18
2018 Q4	$28.7M	Buy	+700,000	New	+$26.2M	3.55%	12

Other funds holding GBT

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boxer Capital's GBT Position: Q4 2020 in Review

Boxer Capital sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2020, closing a stake of 250,000 shares — an estimated $13.8M sold.

Boxer Capital first reported a position in GBT in Q4 2018 and held it in 8 quarters. The position peaked at $28.7M in Q4 2018. 228 funds tracked by Wall St. Rank hold GBT as of Q4 2020.

Boxer Capital reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
Boxer Capital sold 250,000 Global Blood Therapeutics, Inc. shares in Q4 2020, an estimated $13.8M.
Boxer Capital first reported a position in Global Blood Therapeutics, Inc. in Q4 2018 and held it in 8 quarters.
Boxer Capital's Global Blood Therapeutics, Inc. position peaked at $28.7M in Q4 2018.
228 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2020.

Based on Boxer Capital's 13F filing for Q4 2020, filed 16 Feb 2021.